These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22291062)

  • 1. Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP.
    Mesens N; Desmidt M; Verheyen GR; Starckx S; Damsch S; De Vries R; Verhemeldonck M; Van Gompel J; Lampo A; Lammens L
    Toxicol Pathol; 2012 Apr; 40(3):491-503. PubMed ID: 22291062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers to monitor drug-induced phospholipidosis.
    Baronas ET; Lee JW; Alden C; Hsieh FY
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):72-8. PubMed ID: 17156806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of urinary and serum levels of di-22:6-bis(monoacylglycerol)phosphate as noninvasive biomarkers of phospholipidosis in rats.
    Thompson KL; Zhang J; Stewart S; Rosenzweig BA; Shea K; Mans D; Colatsky T
    Toxicol Lett; 2012 Sep; 213(2):285-91. PubMed ID: 22828012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Di-22:6-bis(monoacylglycerol)phosphate: A clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment.
    Liu N; Tengstrand EA; Chourb L; Hsieh FY
    Toxicol Appl Pharmacol; 2014 Sep; 279(3):467-476. PubMed ID: 24967688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the diagnostic accuracy of di-22:6-bis(monoacylglycerol)phosphate and other urinary phospholipids for drug-induced phospholipidosis or tissue injury in the rat.
    Thompson KL; Haskins K; Rosenzweig BA; Stewart S; Zhang J; Peters D; Knapton A; Rouse R; Mans D; Colatsky T
    Int J Toxicol; 2012; 31(1):14-24. PubMed ID: 22267869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.
    Sawada H; Takami K; Asahi S
    Toxicol Sci; 2005 Feb; 83(2):282-92. PubMed ID: 15342952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel set of biomarkers for evaluating phospholipidosis-inducing potential of compounds using rat liver microarray data measured 24-h after single dose administration.
    Yudate HT; Kai T; Aoki M; Minowa Y; Yamada T; Kimura T; Ono A; Yamada H; Ohno Y; Urushidani T
    Toxicology; 2012 May; 295(1-3):1-7. PubMed ID: 22426296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry, with double staining with Nile red and anti-CD3 antibody, to detect phospholipidosis in peripheral blood lymphocytes of rats treated with amiodarone.
    Perico ME; Crivellente F; Faustinelli I; Suozzi A; Cristofori P
    Cell Biol Toxicol; 2009 Dec; 25(6):587-98. PubMed ID: 19105033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary metabolic fingerprinting for amiodarone-induced phospholipidosis in rats using FT-ICR MS.
    Hasegawa M; Takenaka S; Kuwamura M; Yamate J; Tsuyama S
    Exp Toxicol Pathol; 2007 Oct; 59(2):115-20. PubMed ID: 17719757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of a potential biomarker of phospholipidosis from amiodarone-treated rats.
    Mortuza GB; Neville WA; Delaney J; Waterfield CJ; Camilleri P
    Biochim Biophys Acta; 2003 Mar; 1631(2):136-46. PubMed ID: 12633679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bis(monoacylglycero)phosphate, a peculiar phospholipid to control the fate of cholesterol: Implications in pathology.
    Hullin-Matsuda F; Luquain-Costaz C; Bouvier J; Delton-Vandenbroucke I
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):313-24. PubMed ID: 19857945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead-induced phospholipidosis and cholesterogenesis in rat tissues.
    Ademuyiwa O; Agarwal R; Chandra R; Behari JR
    Chem Biol Interact; 2009 May; 179(2-3):314-20. PubMed ID: 19056365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects.
    Martin WJ; Standing JE
    J Pharmacol Exp Ther; 1988 Feb; 244(2):774-9. PubMed ID: 3346847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of lysosomal phospholipase A2 in the catabolism of bis(monoacylglycerol)phosphate and association with phospholipidosis.
    Abe A; Hinkovska-Galcheva V; Bouchev P; Bouley R; Shayman JA
    J Lipid Res; 2024 Jul; 65(7):100574. PubMed ID: 38857781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biomarkers of phospholipidosis in rat blood and heart after amiodarone treatment.
    Bocchini N; Giantin M; Crivellente F; Ferraresso S; Faustinelli I; Dacasto M; Cristofori P
    J Appl Toxicol; 2015 Jan; 35(1):90-103. PubMed ID: 25580480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of a pre-existing phospholipidosis on the accumulation of amiodarone and desethylamiodarone in rat alveolar macrophages.
    Reasor MJ
    Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):169-81. PubMed ID: 1876748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities.
    Tengstrand EA; Miwa GT; Hsieh FY
    Expert Opin Drug Metab Toxicol; 2010 May; 6(5):555-70. PubMed ID: 20370598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Phospholipidosis Is Associated with Altered Hepatobiliary Function as Assessed by Gadoxetate Dynamic Contrast-enhanced Magnetic Resonance Imaging.
    Lenhard SC; Lev M; Webster LO; Peterson RA; Goulbourne CN; Miller RT; Jucker BM
    Toxicol Pathol; 2016 Jan; 44(1):51-60. PubMed ID: 26516164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling in rat liver treated with compounds inducing phospholipidosis.
    Hirode M; Ono A; Miyagishima T; Nagao T; Ohno Y; Urushidani T
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):290-9. PubMed ID: 18355885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled cationic amphiphilic drug-induced pulmonary phospholipidosis in rats and dogs: time-course and dose-response of biomarkers of exposure and effect.
    Pauluhn J
    Toxicology; 2005 Feb; 207(1):59-72. PubMed ID: 15590122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.